美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Maze Therapeutics

9.13

+0.72008.56%

盤後：9.130.00000.00%16:05 EDT

成交量：10.05萬

成交額：88.21萬

市值：4.00億

市盈率：7.30

高：9.16

開：8.38

低：8.33

收：8.41

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

Maze Therapeutics, Inc.2024財年實現淨利潤18.38百萬美元，同比增加118.38%

嗡嗡聲--美國股票走勢-Maze Therapeutics、UFP Technologies、Itron

BUZZ-研究沉寂期過後，券商開始覆蓋，Maze Therapeutics 公司股價上漲

異動解讀 | Maze Therapeutics成功IPO募資,股價盤中大漲6.25%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MAZE"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":9.13,"timestamp":1745265600000,"preClose":8.41,"halted":0,"volume":100502,"hourTrading":{"tag":"盘后","latestPrice":9.13,"preClose":9.13,"latestTime":"16:05 EDT","volume":246,"amount":2245.98,"timestamp":1745265907837},"delay":0,"floatShares":18431500,"shares":43796057,"eps":1.25,"marketStatus":"未開盤","change":0.72,"latestTime":"04-21 16:00:00 EDT","open":8.38,"high":9.16,"low":8.325,"amount":882100.5826,"amplitude":0.099287,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.25,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":8.41,"postHourTrading":{"tag":"盘后","latestPrice":9.13,"preClose":9.13,"latestTime":"16:05 EDT","volume":246,"amount":2245.98,"timestamp":1745265907837},"volumeRatio":0.657736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":18431500,"roa":"23.07%","roe":"50.47%","lyrEps":1.421062,"volumeRatio":0.657736,"shares":43796057,"dividePrice":0,"high":9.16,"amplitude":0.099287,"preClose":8.41,"low":8.325,"week52Low":6.71,"pbRate":"-1.28","psRate":"2.39","week52High":17,"institutionHeld":0,"latestPrice":9.13,"eps":1.25,"divideRate":0,"volume":100502,"delay":0,"ttmEps":1.25,"open":8.38,"prevYearClose":16,"prevWeekClose":8.41,"prevMonthClose":11.01,"prevQuarterClose":11.01,"fiveDayClose":7.83,"twentyDayClose":11.14,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MAZE\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAZE\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524482715","title":"Maze Therapeutics, Inc.2024財年實現淨利潤18.38百萬美元，同比增加118.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524482715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524482715?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 14:00","pubTimestamp":1743573625,"startTime":"0","endTime":"0","summary":"4月2日，Maze Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为18.38百万美元，同比增加118.38%；其中营业收入为1.68亿美元，每股基本收益为0.08美元。从资产负债表来看，Maze Therapeutics, Inc.总负债43.64百万美元，其中短期债务4.63百万美元，资产负债比为0.06，流动比率为0.10。机构评级：截至2025年4月2日，当前有3家机构对Maze Therapeutics, Inc.目标价做出预测，其中目标均价为25.67美元，其中最低目标价为19.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250402140033a44ae443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250402140033a44ae443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MAZE","LENZ"],"gpt_icon":0},{"id":"2514904306","title":"嗡嗡聲--美國股票走勢-Maze Therapeutics、UFP Technologies、Itron","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904306","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904306?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 03:44","pubTimestamp":1740512663,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.11%，报43,508.59点。标准普尔500指数.SPX下跌0.55%，报5950.58点；纳斯达克综合指数.IXIC下跌1.25%，报19045.13点。标准普尔 500 指数.PG.INX涨幅前三名是： ** Solventum Corp SOLV.N，上涨 10.4. ** Concord Medical Services Holdings Ltd CCM.N，上涨 15.7. 纳斯达克.PL.O百分比跌幅前三名： ** Transcode Therapeutics Inc RNAZ.OQ，下跌 42.5. ** Connexa Sports Technologies Inc YYAI.OQ，跌幅 40.9** Li Auto Inc LI.O，下跌 40.9%：。BUZZ - 美国银行开始对减肥药开发商Metsera进行评级，给予 \"买入 \"评级  nL3N3PG101. BUZZ - 美国银行开始对胰岛素设备制造商 Beta Bionics 进行 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG1YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","NVDX","NVDU","NTRA","NVDD","NVD2.UK","STRK","CAKE","PTLO","AHCO","BBIO","HRMY","LVTX","ONVO","NVDY","BGC","SNVD.UK","AXGN","KDP","NVD3.UK","TSYW.SI","UFPT","MAZE","2NVD.UK","PODD","ADIL","NVIW.SI","RETO","EVER","NVDS.UK","ITRI","MTSR","IART","BBNX","GSHD","TNDM","HSIC","DOMH","DNUT"],"gpt_icon":1},{"id":"2514701995","title":"BUZZ-研究沉寂期過後，券商開始覆蓋，Maze Therapeutics 公司股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2514701995","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514701995?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 00:13","pubTimestamp":1740499990,"startTime":"0","endTime":"0","summary":"2月25日 -  ** Maze Therapeutics MAZE.O股价上涨4.8%至11.34美元  ** 随着 IPO  研究平静期的结束，华尔街券商开始看好这家药物开发商 ** 摩根大通开始给予该公司 \"增持 \"评级，目标价为30美元，较上一交易日收盘价上涨177.2%。** 摩根大通、TD Cowen、Leerink Partners 和古根海姆证券是此次 IPO 的承销商。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG1P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAZE","BK4007","BK4207","BK4211","BK4589","SIVBQ","BK4588","BK4585"],"gpt_icon":0},{"id":"1142675045","title":"異動解讀 | Maze Therapeutics成功IPO募資,股價盤中大漲6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1142675045","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142675045?lang=zh_tw&edition=fundamental","pubTime":"2025-02-01 01:22","pubTimestamp":1738344141,"startTime":"0","endTime":"0","summary":"Maze Therapeutics今日股价盘中大涨6.25%,引发市场广泛关注。\n\n消息显示,Maze Therapeutics在今日的IPO中定价为每股16美元,中值于此前公布的定价区间。公司将发行875万股股票,计划募资1.4亿美元。\n\nMaze Therapeutics专注于开发治疗肾脏、心脏和代谢疾病的药物,拥有1.496亿美元的现金储备。该公司的最大股东是Third Rock Ventures的子公司,其他投资者包括ARCH Venture Partners的子公司等知名投资机构。成功IPO将为其持续的药物研发提供资金支持,这可能是促使其股价上涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Maze Therapeutics成功IPO募资,股价盘中大涨6.25%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MAZE"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"MAZE","fiscalQuarterEnding":"2024/12","expectedEps":-7.6,"name":null,"time":"","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"","actualEps":-18.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1740715200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2025-04-17","current":6.858987,"percent":0.092593,"low":6.347498,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"high":12.681398,"avg":9.163226,"sd":1.404668,"marketCap":358251746},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746}],"updateTime":1745296941677}}}